2.98 USD
▲+0.32+1.36%
盘后 2.91 -1.02%
2026-08-03
市值
$2.38M
市盈率
—
EPS
-12.64
股息率
—
52 周区间
2.50 – 22.48
成交量
141.00K
Beta
1.34
目标价
—
52W 低 2.5052W 高 22.48
价格走势
公司简介
Virax Biolabs Group Limited, a biotechnology company, focuses on immune response detection, T cell immune profiling, and the development of in vitro diagnostic technologies for viral and immune-mediated diseases in the United Kingdom, the United States, and China. The company offers ViraxImmune, a T cell-based immune profiling and diagnostic platform for post-acute infection syndromes, including long COVID, myalgic encephalomyelitis / chronic fatigue syndrome, and post-treatment Lyme disease. It also provides ImmuneSelect, a research-use-only p...